According to the recent market analysis, the global Cell Analysis Market size is estimated to reach USD 30.75 billion by 2028, witnessing a healthy growth rate of 8.12% during the forecast period.
Based on techniques, the molecular approaches segment dominated the Cell analysis market in 2022.
Based on product, the consumables segment had the leading Cell analysis market share in 2022.
The North American region captured 41% of the global Cell analysis market share in 2022.
Cell analysis ensures to discover quality drugs in very little time than projected. It also studies the behavior of cells in multicellular and unicellular organisms. In the process of gene identification, cell analysis plays a significant role in monitoring the genetic behavior of the organism. From this cell analysis report, one can study the complete processes of a cell, such as the growth and proliferation of a cell.
Impact of COVID-19 on the cell analysis market:
The COVID-19 pandemic has shown a mixed impact on the cell analysis market. On the one hand, the demand for cell analysis products and services declined and affected the market’s growth rate negatively due to the measures that were taken by several governments such as lockdowns, social distancing and travel bans. Due to these, many research labs were closed or operated at a reduced capacity. In addition, the availability of cell analysis products and services has reduced during the COVID-19 pandemic due to the supply chain disruptions and the shortage of raw materials required for the manufacturing of cell analysis products which hampered the market’s growth rate. On the other hand, the demand for diagnostic testing such as cell-based assays has grown significantly during the COVID-19 pandemic as these tests were used to detect the virus and monitor patient immune responses and this has fuelled the demand for cell analysis products and services and contributed to the market growth. In addition, the demand for automated cell analysis products and services has increased due to the increasing adoption of automation workflows by labs. The COVID-19 pandemic further boosted the adoption of digital technologies in the cell analysis market such as cloud-based platforms for data analysis and remote monitoring of experiments, which have favored the growth of the cell analysis market. Likewise, the cell analysis market has experienced a mixed impact of the COVID-19 pandemic.
The cell analysis technique is a boom for pharmaceutical companies as they can develop various drugs at low cost within the projected time period. This is considered a primary factor propelling the global cell analysis market demand.
Increasing incidences of chronic diseases and other health disorders across the world are secondary factors driving the market's growth. People's demand personalized medicine to have convenient and private treatment procedures is accelerating the growth of the market. Growing research on cells and the launch of innovative products with the help of the cell analysis process boost the demand of the Global Cell Analysis Market. The increasing geriatric population is also an attribute fuelling the rate of cell analysis market growth.
Growing awareness among individuals in the diagnosis and treatment procedures is leveraging the growth rate of the Global Cell Analysis Market. The increasing scale of biopharmaceutical & biotechnological companies is impacting the growth of the market positively. Rising expenditure on healthcare, especially in urban areas, is creating chances for the market to grow. Growth opportunities for the market lie in the increasing number of research and development institutes to improve the quality of the drugs and lavish the demand of the market. The rise in the demand for imaging techniques also escalates the cell analysis market growth.
The adaptation of flow cytometry in novel research applications like proteomics, marine cell biology, and cytogenetics has boosted the cell analysis market growth rate. Also, the rising incidences of HIV and cancer have created the demand for flow cytometry techniques for efficient diagnostics in hospitals and laboratories. Moreover, the advent of reagents and multiple probes for usage in diagnostics and drug discovery is expected to benefit the cause of cell analysis companies targeting the consumers in research/academic areas and small laboratories.
Further, with the advent of cell analysis applications in the oncology domain, the market is expected to experience an unconventional growth rate in the next few years. Cancer cell analysis involves studying tumor cell biology and the development of cell-based therapies and therapeutics for cancer. Considering these novel applications, investments for research in the field of cancer are on the rise, of which the cell assay-based drug developments have gained high importance and interest, thereby amplifying the growth of demand for cell analysis instruments or technologies. According to the WCR Fund, global cancer research funding increases at the rate of 10% annually, resulting in a total expenditure of $177 billion on cancer research. Adding to this trend, the UNITED STATES federal government, Cancer Research U.K, and the Australian government, among others, are also investing in cancer research on a large scale. Recent developments in biomarker technology and stem cell analysis are also providing traction during the forecast period.
The death of skilled persons in the laboratories to analyze the reports is slightly declining the global cell analysis market.
The cost of installing the equipment to perform the process is a bit expensive, which slightly hampering the growth of the Global Cell Analysis Market. Lack of standardization may also degrade the demand of the market quietly. The entry of new players and increasing competition between them is a challenging factor for the market developers. Strict rules and regulations to approve new products are inhibiting the demand of the market.
Market Size Available
2022 to 2028
2023 to 2028
By Type, Production Technologies, Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, APAC, Latin America, Middle East & Africa
Market Leaders Profiled
Bayer HealthCare AG, Bioniche Animal Halth Canada, Sanofi Animal Health, Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Health, Inc., Merck & Co. Inc. and Protein Sciences
This research report segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2028.
Cell Analysis Market Analysis - By Techniques:
Microfluidics and Microarrays
Cell Isolation and Separation
High Content Screening
Based on techniques, the molecular approaches segment held the leading share of the global cell analysis market in 2022 and is expected to grow at a promising CAGR during the forecast period. Under the sub-segments, the PCR segment is predicted to play the leading role during the forecast period. The segmental growth is driven by the growing demand for PCR in research and clinical diagnostics. The microfluidics and microarrays segment is anticipated to register a notable CAGR during the forecast period owing to the increasing adoption of microfluidics and microarrays for high-throughput screening, drug discovery, and disease diagnosis.
The image-based approach segment is estimated to grow at a healthy CAGR during the forecast period. Under the sub-segments, the high-content screening segment is predicted to register a noteworthy CAGR during the forecast period owing to the increasing adoption of high-content screening for drug discovery, toxicity testing, and disease diagnosis. On the other hand, the cytometry and microscopy segments are predicted to witness a notable CAGR during the forecast period.
Cell Analysis Market Analysis - By Product:
Cell Culture Consumables
Cell Microarrays and Microfluidics
Liquid Handling Systems
High Content Screening Systems
Software and Services
Based on product, the consumables segment had the largest share of the worldwide market in 2022 and is expected to grow at a healthy CAGR during the forecast period. The segmental growth is attributed to the increasing demand for cell-based assays and reagents in drug discovery, personalized medicine, and regenerative medicine. In addition, the growing prevalence of chronic diseases, such as cancer and cardiovascular diseases is fuelling the demand for consumables and boosting the segment’s growth rate.
The instruments segment is estimated to grow at a noteworthy CAGR during the forecast period. The growth rate of the segment is majorly fuelled by the increasing adoption of advanced technologies, such as microfluidics, high-throughput screening, and next-generation sequencing and the growing demand for automated and high-throughput instruments for cell analysis.
The software and services segment is predicted to witness the fastest CAGR during the forecast period owing to the increasing demand for data analysis and interpretation tools in cell analysis, the rising complexity of cell analysis data and the need for accurate and reproducible results and increasing adoption of contract research services and outsourcing of cell analysis.
Cell Analysis Market Analysis – By Application:
By Process of Application
Signal Transduction Pathway
Circulating Tumor Cells
Epigenetic Target Analysis
Drug and Candidate Screening
By Field of Application
Stem Cell Analysis
By Therapeutic Area of Applications
Based on the application, the therapeutic area segment is expected to register a healthy CAGR during the forecast period. The growth of the segmental is majorly driven by the growing demand for cell analysis in the diagnosis and treatment of various diseases, rising prevalence of chronic diseases, such as cancer and cardiovascular diseases and the need for personalized medicine and targeted therapies.
Cell Analysis Market Analysis – By End-User:
Academic & Research Laboratories
Pharmaceuticals and Biotech Companies
Based on end-user, the pharmaceutical and biotech companies segment had the major share of the global cell analysis market in 2022 and is expected to grow at a prominent CAGR during the forecast period. Factors such as increasing demand for new drug development, personalized medicine, and targeted therapies, increasing prevalence of chronic diseases, the growing need for effective therapies, and increasing adoption of automation and high-throughput instruments in pharmaceutical and biotech companies primarily drive segmental growth.
Cell Analysis Market Analysis – By Region:
North America Cell Analysis Market
Europe Cell Analysis Market
Asia-Pacific Cell Analysis Market
Latin America Cell Analysis Market
Middle East & Africa Cell Analysis Market
Geographically, North America held the largest share of the global cell analysis market in 2022 and the domination of the region is expected to continue during the forecast period. The growth of the North American region in the worldwide market is attributed to the growing disposable income, rising prevalence to have cost-effective drugs and the presence of major pharmaceutical and biotech companies, academic and research institutions, and advanced healthcare infrastructure. In addition, factors such as the growing demand for personalized medicine, and increasing investment in R&D activities and the presence of key market players, such as Thermo Fisher Scientific, Becton, Dickinson and Company, and Danaher Corporation further fuel the growth rate of the North American market. The U.S. market held around 81% of the North American market in 2022 and is expected to grow at a prominent CAGR during the forecast period.
Europe was the second biggest regional market for cell analysis worldwide in 2022 and is expected to grow at a notable CAGR during the forecast period. The growth of the European market is driven by factors such as growing funding by the European governments for R&D, increasing adoption pf personalized medicine, and the presence of sophisticated healthcare infrastructure. The increasing adoption of advanced technologies and the presence of key market players, such as F. Hoffmann-La Roche Ltd and Agilent Technologies further boost the growth of the European market. The United Kingdom, Germany, and France are predicted to account for the major share of the European market during the forecast period.
APAC is the fastest-growing regional market for cell analysis and is estimated to register the highest CAGR in the worldwide market among all the regions. Factors such as the growing patient population of various life-threatening diseases, increasing investments for R&D by private organizations and the growing number of improvements in the healthcare infrastructure drive the growth of the APAC market. China, Japan, and India accounted for the major share of the worldwide market in 2022 and the same trend is predicted to continue throughout the forecast period.
Latin America is a noteworthy regional market for cell analysis worldwide and is expected to grow at a steady CAGR during the forecast period. Mexico and Brazil are estimated to hold the major share of the Latin American market during the forecast period.
MEA had a moderate CAGR of the worldwide market in 2022 and is predicted to grow at a slow CAGR during the forecast period. South Africa, Saudi Arabia, and the United Arab Emirates are estimated to have the major share of the MEA market during the forecast period owing to the increasing government funding for healthcare infrastructure and the rising demand for personalized medicine.
KEY MARKET PARTICIPANTS:
Some of the notable companies leading the global cell analysis market profiled in this report are Becton, Dickinson, and Company (United States), Thermo Fisher Scientific, Inc. (UNITED STATES), Merck KGaA (Germany), Danaher Corporation (UNITED STATES), GE Corporation (United Kingdom), Olympus Corporation (Japan), Agilent Technologies, Inc. (UNITED STATES), PerkinElmer, Inc. (UNITED STATES), Promega Corporation (UNITED STATES), Tecan Group Ltd. (Switzerland).
Recent Market Developments:
Product Launch - In August 2019, a multimode real-time cell analyzer (RTCA) was launched by Agilent Technologies. This is the first kind of product introduced with the combination of non-invasive biosensors and live-cell imaging. This company is has started research mainly on immuno-oncology and immunotherapy applications.
Product Launch - On June 24, 2019, Sony launched the ID7000™ flagship spectral cell analyzer, which is capable of streamlining multicolor cell analysis for more than 44 colors. The launch of this product will empower deep insights into cell information and also boost up the growth in the market.
Product Launch - In April 2019, a product for BioPharma named Vi-CELL BLE cell viability analyzer was introduced by Beckman Coulter. This product has high demand in the coming years as this shows great viability in monitoring the cell in laboratories.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org